Microsatellite instability in ductal carcinoma in situ of the breast

被引:0
|
作者
Walsh, T
Chappell, SA
Shaw, JA
Walker, RA
机构
[1] Univ Leicester, Glenfield Hosp, Dept Pathol, Breast Canc Res Unit, Leicester LE3 9QP, Leics, England
[2] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England
来源
JOURNAL OF PATHOLOGY | 1998年 / 185卷 / 01期
关键词
ductal carcinoma in situ; microdissection; microsatellite instability; DM-1; alterations; mismatch repair protein expression;
D O I
10.1002/(SICI)1096-9896(199805)185:1<18::AID-PATH41>3.0.CO;2-G
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Microsatellite instability (MI+) is associated with defects in mismatch repair, resulting in a 'mutator' phenotype and the development and progression of cancer. MI+ has been documented in invasive breast carcinomas. This study was undertaken to determine whether MI+ is found in the early non-invasive form of breast cancer, ductal carcinoma in situ (DCIS). We examined microdissected ducts from 23 cases of DCIS with 11 markers comprising mono-, di-, and trinucleotide repeats from six chromosomal regions. Five tumours (22 per cent) displayed MI+ at two or more loci, in all ducts examined. A further seven (30 per cent) tumours showed alterations at a single locus (the DM-1 trinucleotide), and for two of these, heterogeneity between ducts was observed. Alterations at microsatellite repeat motifs in the coding regions of four cancer-associated genes (TGF beta RII, IGFIIR, BAX, and E2F-4) were not observed. Immunohistochemistry revealed that there was no loss of reactivity: for the mismatch repair proteins, MLH1, MSH2, and PMS2, in the DCIS cases. In general, MI+ tumours and those with alterations at the DM-1 microsatellite were predominantly of higher nuclear grade and expressing c-erbB-2, suggesting that aberrations in DNA repair functions may lead to the acquisition of a more aggressive phenotype in breast cancer. (C) 1998 John Wiley & Sons, Ltd.
引用
收藏
页码:18 / 24
页数:7
相关论文
共 50 条
  • [1] Loss of heterozygosity and microsatellite instability in ductal carcinoma in situ of the breast
    Ando, Y
    Iwase, H
    Ichihara, S
    Toyoshima, S
    Nakamura, T
    Yamashita, H
    Toyama, T
    Omoto, Y
    Karamatsu, S
    Mitsuyama, S
    Fujii, Y
    Kobayashi, S
    CANCER LETTERS, 2000, 156 (02) : 207 - 214
  • [2] Ductal Carcinoma In Situ of the Breast
    Siziopikou, Kalliopi P.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (04) : 462 - 466
  • [3] Ductal Carcinoma In Situ of the Breast
    Vaidya, Yash
    Vaidya, Pradeep
    Vaidya, Tanvi
    INDIAN JOURNAL OF SURGERY, 2015, 77 (02) : 141 - 146
  • [4] Ductal Carcinoma In Situ of the Breast
    Lee, Richard J.
    Vallow, Laura A.
    McLaughlin, Sarah A.
    Tzou, Katherine S.
    Hines, Stephanie L.
    Peterson, Jennifer L.
    INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY, 2012, 2012
  • [5] IN SITU DUCTAL CARCINOMA OF BREAST
    JOHNSON, J
    JACKSON, TL
    MILLER, W
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1962, 181 (11): : 1000 - &
  • [6] Ductal carcinoma in situ of the breast
    Pfisterer, J
    ONKOLOGIE, 1999, 22 : 22 - 24
  • [7] Ductal carcinoma in situ of the breast
    Fonseca, R
    Hartmann, LC
    Petersen, IA
    Donohue, JH
    Crotty, TB
    Gisvold, JJ
    ANNALS OF INTERNAL MEDICINE, 1997, 127 (11) : 1013 - 1022
  • [8] Ductal carcinoma in situ of the breast
    Layfield, LJ
    HUMAN PATHOLOGY, 1998, 29 (11) : 1329 - 1330
  • [9] Ductal carcinoma in situ of the breast
    Peterson, Jennifer L.
    Vallow, Laura A.
    Hines, Stephanie L.
    Buskirk, Steven J.
    ONCOLOGY REVIEWS, 2009, 3 (04) : 237 - 246
  • [10] Ductal carcinoma in situ of the breast
    Silverstein, MJ
    ANNUAL REVIEW OF MEDICINE, 2000, 51 : 17 - 32